Price Jackson
Price Jackson
Peter MacCallum Cancer Centre
Verified email at petermac.org
Title
Cited by
Cited by
Year
Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy
WN Rahman, N Bishara, T Ackerly, CF He, P Jackson, C Wong, ...
Nanomedicine: Nanotechnology, Biology and Medicine 5 (2), 136-142, 2009
4052009
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ...
The Lancet Oncology 19 (6), 825-833, 2018
3562018
Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents
PA Jackson, WNWA Rahman, CJ Wong, T Ackerly, M Geso
European journal of radiology 75 (1), 104-109, 2010
1062010
Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes
J Violet, P Jackson, J Ferdinandus, S Sandhu, T Akhurst, A Iravani, ...
Journal of Nuclear Medicine 60 (4), 517-523, 2019
802019
An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging
PA Jackson, JM Beauregard, MS Hofman, T Kron, A Hogg, RJ Hicks
Medical physics 40 (11), 112503, 2013
562013
Long-term follow-up and outcomes of retreatment in an expanded 50-patient single-center phase II prospective trial of 177Lu-PSMA-617 theranostics in metastatic castration …
J Violet, S Sandhu, A Iravani, J Ferdinandus, SP Thang, G Kong, ...
Journal of Nuclear Medicine 61 (6), 857-865, 2020
472020
Evaluation of the effects of gold nanoparticle shape and size on contrast enhancement in radiological imaging
P Jackson, S Periasamy, V Bansal, M Geso
Australasian physical & engineering sciences in medicine 34 (2), 243, 2011
402011
Deep learning renal segmentation for fully automated radiation dose estimation in unsealed source therapy
P Jackson, N Hardcastle, N Dawe, T Kron, MS Hofman, RJ Hicks
Frontiers in oncology 8, 215, 2018
362018
Analysis of 177Lu-DOTA-octreotate therapy–induced DNA damage in peripheral blood lymphocytes of patients with neuroendocrine tumors
D Denoyer, P Lobachevsky, P Jackson, M Thompson, OA Martin, ...
Journal of Nuclear Medicine 56 (4), 505-511, 2015
352015
Cold kit for prostate-specific membrane antigen (PSMA) PET imaging: phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
MS Hofman, P Eu, P Jackson, E Hong, D Binns, A Iravani, D Murphy, ...
Journal of Nuclear Medicine 59 (4), 625-631, 2018
342018
Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose–response relationship
S Siva, P Jackson, T Kron, M Bressel, E Lau, M Hofman, M Shaw, ...
Radiotherapy and Oncology 118 (3), 540-546, 2016
322016
Role of epidermal growth factor and transforming growth factor α in the developing stomach: These data were presented at the spring meeting of the British Society of …
EJ Kelly, SJ Newell, KG Brownlee, SM Farmery, C Cullinane, WA Reid, ...
Archives of Disease in Childhood-Fetal and Neonatal Edition 76 (3), F158-F162, 1997
291997
Rapid blood clearance and lack of long-term renal toxicity of 177 Lu-DOTATATE enables shortening of renoprotective amino acid infusion
R Kashyap, P Jackson, MS Hofman, P Eu, JM Beauregard, D Zannino, ...
European journal of nuclear medicine and molecular imaging 40 (12), 1853-1860, 2013
272013
timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial 99m Tc-DMSA SPECT/CT
P Jackson, F Foroudi, D Pham, MS Hofman, N Hardcastle, J Callahan, ...
Radiation Oncology 9 (1), 1-4, 2014
252014
64Cu-SARTATE PET imaging of patients with neuroendocrine tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor …
RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman, DA Pattison, ...
Journal of Nuclear Medicine 60 (6), 777-785, 2019
242019
Accuracy and utility of deformable image registration in 68Ga 4D PET/CT assessment of pulmonary perfusion changes during and after lung radiation therapy
N Hardcastle, MS Hofman, RJ Hicks, J Callahan, T Kron, MP MacManus, ...
International Journal of Radiation Oncology* Biology* Physics 93 (1), 196-204, 2015
192015
Cold Kit PSMA PET Imaging: Phase I study of 68Ga-THP-PSMA PET/CT in patients with prostate cancer
MS Hofman, P Eu, P Jackson, E Hong, D Binns, A Iravani, D Murphy, ...
Journal of Nuclear Medicine, jnumed. 117.199554, 2017
142017
Radiation dosimetry in 177Lu-PSMA-617 therapy using a single posttreatment SPECT/CT scan: a novel methodology to generate time-and tissue-specific dose factors
PA Jackson, MS Hofman, RJ Hicks, M Scalzo, J Violet
Journal of Nuclear Medicine 61 (7), 1030-1036, 2020
102020
Voxel‐wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated …
HM Reynolds, S Williams, P Jackson, C Mitchell, MS Hofman, RJ Hicks, ...
BJU international 123 (6), 1020-1030, 2019
92019
High activity, pain reduction and low toxicity with Lutetium-177 PSMA617 theranostics in metastatic castrate-resistant prostate cancer (mCRPC): results of a phase II …
M Hofman, J Violet, S Sandhu, J Ferdinandus, SP Thang, A Iravani, ...
Journal of Nuclear Medicine 59 (supplement 1), 531-531, 2018
92018
The system can't perform the operation now. Try again later.
Articles 1–20